LumiCyte works inthe field of proteomics using protein BioChip-driven informatics products that will revolutionize medicine. These service products are expected to enable aggregation, analysis, and dissemination of protein information - providing the information bridge and products needed to help deliver the value anticipated from the completion of the Human Genome Project. LumiCyte's patented BioChips are used for generating comprehensive molecular protein information from human plasma, saliva or urine. From asingle drop of blood, this protein profile information can help determine an individual's health status, from the early detection of disease onset to the monitoring of response to drug therapy. This individualized protein profile information is comprehensive enough to dramatically improve theeffectiveness of drug development efforts and the routine delivery ofhealthcare. LumiCyte is building a health- and disease-specific proteomics database by collecting protein profiles on a scale not possible before now. The unique computer-based design of LumiCyte's BioChips enables the direct integration of its protein profiles with information derived from existing genomics, proteomics, and clinical databases. The fusion of these molecular and clinical databases, and the mining ofthe aggregated content define LumiCyte's powerful BioPhore Knowledgebase. The BioPhore Knowledgebase will be the worlds first Internet-based platform of aggregated and integrated bioinformaticsfocused on the delivery of individualized healthcare.
